NCT06392594View on ClinicalTrials.gov

Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB

Not yet recruitingOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

April 23, 2024

Primary Completion Date

April 23, 2025

Study Completion Date

May 23, 2025

Conditions
Tuberculosis, Pulmonary
Interventions
GENETIC

xpert MTB , XDR assay

To determine how accurate Xpert MTB/RIF and XDR for diagnosis of pulmonary TB and Rifampicin resistance

All Listed Sponsors
lead

Assiut University

OTHER

NCT06392594 - Performance of Xpert MTB/RIF and XDR Assay for Diagnosis of Pulmonary Tuberculosis and Resistant Pulmonary TB | Biotech Hunter | Biotech Hunter